Entia Biosciences, Inc. (ERGO)
0.001
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Entia Biosciences Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2016 | 78.04% |
| September 30, 2016 | 67.78% |
| June 30, 2016 | 63.82% |
| March 31, 2016 | 59.09% |
| December 31, 2015 | 54.53% |
| September 30, 2015 | 68.38% |
| June 30, 2015 | 56.80% |
| March 31, 2015 | 69.11% |
| December 31, 2014 | 63.69% |
| September 30, 2014 | 54.33% |
| June 30, 2014 | 65.42% |
| March 31, 2014 | 63.16% |
| December 31, 2013 | 24.57% |
| September 30, 2013 | 51.90% |
| June 30, 2013 | 48.85% |
| Date | Value |
|---|---|
| March 31, 2013 | 70.30% |
| December 31, 2012 | 56.89% |
| September 30, 2012 | 67.49% |
| June 30, 2012 | 74.44% |
| March 31, 2012 | 90.39% |
| December 31, 2011 | 65.96% |
| September 30, 2011 | 86.00% |
| June 30, 2011 | 60.34% |
| March 31, 2011 | 53.21% |
| December 31, 2010 | 62.57% |
| September 30, 2010 | 59.05% |
| June 30, 2010 | 63.12% |
| March 31, 2010 | 21.69% |
| December 31, 2009 | -31.05% |
| September 30, 2009 | 35.59% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Trident Brands, Inc. | -- |
| Nunzia Pharmaceutical Corp. | -- |
| Cyanotech Corp. | 42.38% |
| Mannatech, Inc. | 75.90% |
| Natural Alternatives International, Inc. | 4.22% |